Literature DB >> 14747215

Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.

Stephen Colagiuri1, Zafirul Hussain, Paul Zimmet, Adrian Cameron, Jonathan Shaw.   

Abstract

OBJECTIVE: To assess the Australian protocol for identifying undiagnosed type 2 diabetes and impaired glucose metabolism. RESEARCH DESIGN AND METHODS: The Australian screening protocol recommends a stepped approach to detecting undiagnosed type 2 diabetes based on assessment of risk status, measurement of fasting plasma glucose (FPG) in individuals at risk, and further testing according to FPG. The performance of and variations to this protocol were assessed in a population-based sample of 10,508 Australians.
RESULTS: The protocol had a sensitivity of 79.9%, specificity of 79.9%, and a positive predictive value (PPV) of 13.7% for detecting undiagnosed type 2 diabetes and sensitivity of 51.9% and specificity of 86.7% for detecting impaired glucose tolerance (IGT) or impaired fasting glucose (IFG). To achieve these diagnostic rates, 20.7% of the Australian adult population would require an oral glucose tolerance test (OGTT). Increasing the FPG cut point to 6.1 mmol/l (110 mg/dl) or using HbA(1c) instead of FPG to determine the need for an OGTT in people with risk factors reduced sensitivity, increased specificity and PPV, and reduced the proportion requiring an OGTT. However, each of these protocol variations substantially reduced the detection of IGT or IFG.
CONCLUSIONS: The Australian screening protocol identified one new case of diabetes for every 32 people screened, with 4 of 10 people screened requiring FPG measurement and 1 in 5 requiring an OGTT. In addition, 1 in 11 people screened had IGT or IFG. Including HbA(1c) measurement substantially reduced both the number requiring an OGTT and the detection of IGT or IFG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747215     DOI: 10.2337/diacare.27.2.367

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  17 in total

1.  San Antonio heart study diabetes prediction model applicable to a Middle Eastern population? Tehran glucose and lipid study.

Authors:  Mohammadreza Bozorgmanesh; Farzad Hadaegh; Azadeh Zabetian; Fereidoun Azizi
Journal:  Int J Public Health       Date:  2010-03-09       Impact factor: 3.380

2.  How can we identify candidates at highest risk--to screen or not to screen?

Authors:  N C Barengo; J O Tuomilehto
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

3.  Awareness of Pre-diabetes or Diabetes and Associated Factors in People With Psychosis.

Authors:  Debra L Foley; Andrew Mackinnon; Vera A Morgan; Gerald F Watts; David J Castle; Anna Waterreus; Cherrie A Galletly
Journal:  Schizophr Bull       Date:  2016-05-05       Impact factor: 9.306

4.  TRAF4 functions as an intermediate of GITR-induced NF-kappaB activation.

Authors:  E M Esparza; R H Arch
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

5.  Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.

Authors:  R Doerr; U Hoffmann; W Otter; L Heinemann; W Hunger-Battefeld; B Kulzer; A Klinge; V Lodwig; I Amann-Zalan; D Sturm; D Tschoepe; S G Spitzer; J Stumpf; T Lohmann; O Schnell
Journal:  Diabetologia       Date:  2011-07-20       Impact factor: 10.122

6.  Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care.

Authors:  M Y Bertram; S S Lim; J J Barendregt; T Vos
Journal:  Diabetologia       Date:  2010-02-05       Impact factor: 10.122

7.  Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence.

Authors:  David Preiss; Naveed Sattar
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

8.  Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China.

Authors:  Xianghai Zhou; Zengchang Pang; Weiguo Gao; Shaojie Wang; Lei Zhang; Feng Ning; Qing Qiao
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 19.112

9.  Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults.

Authors:  Ilhan Satman; Beyhan Omer; Yildiz Tutuncu; Sibel Kalaca; Selda Gedik; Nevin Dinccag; Kubilay Karsidag; Sema Genc; Aysegul Telci; Bulent Canbaz; Fulya Turker; Temel Yilmaz; Bekir Cakir; Jaakko Tuomilehto
Journal:  Eur J Epidemiol       Date:  2013-02-14       Impact factor: 8.082

10.  The Utility of HbA1c as a Diagnostic Criterion of Diabetes.

Authors:  Hee-Jung Kim; Eun Young Choi; Eal Whan Park; Yoo Seock Cheong; Hong-Yoen Lee; Ji Hyun Kim
Journal:  Korean J Fam Med       Date:  2011-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.